Zugriffe | |
---|---|
GD2-directed bispecific trifunctional antibody outperforms dinutuximab beta in a murine model for aggressive metastasized neuroblastoma | 78 |
März 2023 | April 2023 | Mai 2023 | Juni 2023 | Juli 2023 | August 2023 | September 2023 | |
---|---|---|---|---|---|---|---|
GD2-directed bispecific trifunctional antibody outperforms dinutuximab beta in a murine model for aggressive metastasized neuroblastoma | 0 | 1 | 4 | 3 | 0 | 3 | 1 |
Zugriffe | |
---|---|
2021_Zirngibl_etal.pdf | 119 |